415 related articles for article (PubMed ID: 9703957)
1. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
[TBL] [Abstract][Full Text] [Related]
2. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
[TBL] [Abstract][Full Text] [Related]
3. Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase.
De Petrocellis L; Melck D; Ueda N; Maurelli S; Kurahashi Y; Yamamoto S; Marino G; Di Marzo V
Biochem Biophys Res Commun; 1997 Feb; 231(1):82-8. PubMed ID: 9070224
[TBL] [Abstract][Full Text] [Related]
4. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V
Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090
[TBL] [Abstract][Full Text] [Related]
5. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide.
Di Marzo V; Bisogno T; Sugiura T; Melck D; De Petrocellis L
Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):15-9. PubMed ID: 9512456
[TBL] [Abstract][Full Text] [Related]
6. N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus.
Gobira PH; Lima IV; Batista LA; de Oliveira AC; Resstel LB; Wotjak CT; Aguiar DC; Moreira FA
J Psychopharmacol; 2017 Jun; 31(6):750-756. PubMed ID: 28583049
[TBL] [Abstract][Full Text] [Related]
7. Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma 'anandamide amidohydrolase'.
Maurelli S; Bisogno T; De Petrocellis L; Di Luccia A; Marino G; Di Marzo V
FEBS Lett; 1995 Dec; 377(1):82-6. PubMed ID: 8543025
[TBL] [Abstract][Full Text] [Related]
8. Interactions between synthetic vanilloids and the endogenous cannabinoid system.
Di Marzo V; Bisogno T; Melck D; Ross R; Brockie H; Stevenson L; Pertwee R; De Petrocellis L
FEBS Lett; 1998 Oct; 436(3):449-54. PubMed ID: 9801167
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
[TBL] [Abstract][Full Text] [Related]
10. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
[TBL] [Abstract][Full Text] [Related]
11. The sleep inducing factor oleamide is produced by mouse neuroblastoma cells.
Bisogno T; Sepe N; De Petrocellis L; Mechoulam R; Di Marzo V
Biochem Biophys Res Commun; 1997 Oct; 239(2):473-9. PubMed ID: 9344854
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
Lichtman AH; Hawkins EG; Griffin G; Cravatt BF
J Pharmacol Exp Ther; 2002 Jul; 302(1):73-9. PubMed ID: 12065702
[TBL] [Abstract][Full Text] [Related]
13. Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide.
Day TA; Rakhshan F; Deutsch DG; Barker EL
Mol Pharmacol; 2001 Jun; 59(6):1369-75. PubMed ID: 11353795
[TBL] [Abstract][Full Text] [Related]
14. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
Ortar G; Ligresti A; De Petrocellis L; Morera E; Di Marzo V
Biochem Pharmacol; 2003 May; 65(9):1473-81. PubMed ID: 12732359
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation.
Bisogno T; Katayama K; Melck D; Ueda N; De Petrocellis L; Yamamoto S; Di Marzo V
Eur J Biochem; 1998 Jun; 254(3):634-42. PubMed ID: 9688276
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V
Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699
[TBL] [Abstract][Full Text] [Related]
17. New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain.
Ortar G; Cascio MG; De Petrocellis L; Morera E; Rossi F; Schiano-Moriello A; Nalli M; de Novellis V; Woodward DF; Maione S; Di Marzo V
J Med Chem; 2007 Dec; 50(26):6554-69. PubMed ID: 18027904
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.
Onnis V; Congiu C; Björklund E; Hempel F; Söderström E; Fowler CJ
J Med Chem; 2010 Mar; 53(5):2286-98. PubMed ID: 20143779
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications.
Bisogno T; De Petrocellis L; Di Marzo V
Curr Pharm Des; 2002; 8(7):533-47. PubMed ID: 11945157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
